Medical Disclaimer | This article is for informational and educational purposes only and does not constitute medical advice. Chronic insomnia is a medical condition that benefits from professional evaluation. CBD is not an FDA-approved treatment for insomnia. Always consult a healthcare provider before starting CBD, especially if taking prescription sleep medications. The content on this page has not been evaluated by the FDA. PureCraft CBD products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.

The internet is full of confident claims about CBD and sleep — from 'CBD cures insomnia' to 'CBD has no proven sleep benefit.' Both are wrong. The actual research tells a more nuanced and ultimately more useful story: CBD's sleep evidence is genuinely strong for specific types of insomnia, specifically those driven by anxiety, stress, and HPA dysregulation, and meaningfully weaker for primary insomnia without these drivers.
This post gives you the unvarnished version of the evidence — every major published study, what each found, what its limitations are, and what it means for your specific sleep situation. Understanding which type of insomnia you have is more important than knowing whether CBD 'works for sleep' in the abstract.
For the complete sleep science foundation underlying everything in this post, start with theCBD for Sleep: The Complete Science-Backed Guide. For the anxiety dimension that drives the most CBD-responsive type of insomnia, seeCBD for Anxiety and Sleep: Breaking the Cycle. This is Supporting Post 1 in PureCraft's Sleep Cluster.
Insomnia is defined as difficulty initiating or maintaining sleep, or non-restorative sleep, occurring at least three nights per week for at least three months, causing significant daytime distress or impairment. This clinical definition encompasses several neurobiologically distinct conditions that respond differently to CBD:
Primary insomnia occurs without a clearly identified underlying cause — no anxiety disorder, no chronic pain, no PTSD, no medical condition driving the sleep disruption. The neurobiology may involve conditioned arousal (the bedroom itself becomes a wakefulness trigger through learned association), circadian dysregulation, sleep drive abnormalities, or factors that remain incompletely characterized. This is the hardest type of insomnia for CBD to address, because CBD's mechanisms are most relevant to anxiety-HPA-mediated sleep disruption — which primary insomnia may not involve.
Secondary insomnia occurs as a consequence of another condition: anxiety disorder (most common in CBD users), depression, chronic pain, PTSD, medical conditions, or medication side effects. When anxiety is the driver — which is the case for the majority of people seeking CBD for sleep — the sleep disruption has a specific neurobiological cause (elevated cortisol blocking melatonin, amygdala hypervigilance preventing neurological disengagement) that CBD's mechanisms directly address. Treating the anxiety treats the sleep.
Why this distinction matters for CBD:CBD's most important sleep mechanisms (HPA cortisol modulation, 5-HT1A anxiolytic, FAAH/anandamide ECS restoration) are mechanisms that address the neurobiological drivers of secondary anxiety-insomnia specifically. They are not general sleep-forcing mechanisms. This explains the clinical pattern: the most consistent CBD sleep evidence comes from populations where anxiety or stress is clearly driving the sleep disruption. For the full mechanism breakdown, seeCBD for Sleep: The Complete Science-Backed Guide.
The following table covers the published clinical evidence for CBD and sleep. Unlike typical CBD content that cherry-picks favorable studies, this table includes every significant published study with honest quality assessments — including limitations that context requires.
|
Study |
Population |
Design |
CBD Dose |
Sleep Finding |
What It Tells Us |
|
Shannon et al. (2019) The Permanente Journal |
72 adults presenting to psychiatric clinic with anxiety + sleep complaints |
Retrospective case series — real-world clinical patients |
25mg daily (most patients) |
66.7% reported improved sleep scores at 1 month; sustained at 3 months; sleep improvement correlated with anxiety improvement |
Largest real-world CBD sleep dataset; 25mg daily effective for most; anxiety-sleep coupling confirmed — treating anxiety improved sleep |
|
Chagas et al. (2014) Journal of Psychopharmacology |
15 Parkinson's disease patients with REM sleep behavior disorder |
Crossover RCT — multiple CBD doses tested |
75mg, 150mg, and 300mg (acute doses) |
300mg CBD significantly reduced REM sleep behavior disorder symptoms; 75mg not significantly different from placebo; dose-response confirmed |
Dose matters — 300mg showed clear effect where 75mg did not; REM behavior disorder specifically responsive; Parkinson's population |
|
Babson et al. (2017) Current Psychiatry Reports |
Systematic review — anxiety, PTSD, and pain populations with sleep disruption |
Systematic review of available evidence |
Various across reviewed studies |
Consistent evidence for CBD improving sleep in populations where disruption is secondary to anxiety, PTSD, or pain; weaker evidence for primary insomnia without these drivers |
Establishes the secondary insomnia pattern — CBD works best when sleep disruption has a defined anxiety/HPA cause |
|
de Aquino et al. (2020) Frontiers in Psychiatry |
37 adults with treatment-resistant anxiety — sleep disruption as secondary endpoint |
Pilot RCT (placebo-controlled) |
150–300mg daily |
Both anxiety AND sleep disruption significantly improved vs. placebo; sleep improvement correlated with anxiety improvement — anxiety treatment drove sleep benefit |
Confirms anxiety-sleep coupling in RCT design; treatment-resistant population means CBD reached dimensions standard treatment missed |
|
Suraev et al. (2020) Sleep Medicine Reviews |
Systematic review of cannabinoid sleep research |
Systematic review with evidence quality assessment |
Various |
CBD shows promise for anxiety-related sleep disruption; evidence for direct hypnotic effect weaker; CBN and combination products suggested for sleep-specific applications |
Most rigorous summary to date; honest about evidence gaps for primary insomnia; validates combination approach |
|
Saleska et al. (2021) Medicines |
409 adults with self-reported sleep concerns — observational study |
Survey-based observational study |
Varying CBD doses and products |
Nearly half of CBD users reported using CBD primarily for sleep; majority reported positive sleep effects; dose and product type varied widely |
Large real-world survey; confirms CBD use for sleep is widespread and self-reported positive; not controlled but shows population-level pattern |
Taken together, the published evidence supports several conclusions with reasonable confidence:

The most important step in evaluating whether CBD is likely to help your insomnia is identifying which type you have. The following table maps six insomnia presentations to CBD's evidence base and expected response. For the complete sleep type analysis, see thesleep pillar's matching table.
|
Insomnia Type |
Defining Characteristics |
CBD Fit |
Primary CBD Mechanism |
Realistic Expectation |
|
Sleep onset insomnia (anxiety-driven) |
Racing mind at bedtime; cannot switch off thoughts; anxiety peaks when quiet; 30+ min to fall asleep despite exhaustion |
Excellent — this is CBD's strongest sleep application; anxiety is the root cause, CBD's mechanisms address it directly |
5-HT1A anxiolytic; HPA cortisol reduction enabling melatonin; CBN arousal reduction in Sleep Gummies |
Strong improvement likely within 1–3 weeks of consistent bedtime gummy + daily AM oil |
|
Sleep onset insomnia (non-anxiety) |
Difficulty falling asleep without anxiety; possibly circadian timing issue; no racing mind; physiological arousal barrier |
Moderate — melatonin and CBN components of Sleep Gummies most relevant; CBD's anxiety mechanism less applicable without anxiety driver |
Melatonin circadian timing signal; CBN mild sedation; CBD contributes less without anxiety dimension |
Modest improvement; CBT-I should be primary treatment for primary insomnia; Sleep Gummies helpful adjunct |
|
Sleep maintenance insomnia (early morning waking) |
Falls asleep adequately; wakes at 2–4am with anxiety or cannot return to sleep; the exaggerated early-morning cortisol pulse in HPA-dysregulated individuals |
Good with patience — daily AM oil's cumulative HPA recalibration reduces the exaggerated early-morning cortisol pulse; this is the slowest-responding pattern |
Cumulative HPA recalibration from daily AM Nano CBD Oil is the primary mechanism; bedtime gummy addresses onset but not necessarily maintenance |
Expect 4–6 weeks of consistent daily AM oil before early-morning waking frequency reduces; do not take additional CBD at 3am |
|
Stress-related insomnia (acute/situational) |
Sleep disruption tied to identifiable stressor; present during stress period; typically resolves when stressor resolves; cortisol pattern similar to anxiety-insomnia but more acute |
Good for the stress period — HPA modulation reduces the acute cortisol load; Sleep Gummies effective for immediate relief |
Acute HPA cortisol modulation; Sleep Gummy three-mechanism approach for the stress period |
Good response during acute stress period (1–2 weeks); may not need ongoing daily protocol once stressor resolves |
|
Pain-related insomnia |
Pain disrupts sleep onset and maintenance; nocturnal pain awareness increases as daytime distraction disappears; inflammation-driven arousal |
Moderate — TRPV1 desensitization, CB2 anti-inflammatory, and Sleep Gummies all contribute; addressing pain directly (CBD topicals for localized pain) may be as important as CBD oil for this type |
TRPV1 desensitization; CB2 anti-inflammatory; anxiolytic component helps if pain produces secondary anxiety |
Modest to moderate; pain is not eliminated; expect 3–4 weeks for initial improvement; may need topicals for localized pain dimension |
|
PTSD nightmares / hyperarousal insomnia |
Nightmares from fear memory reactivation in REM; hyperarousal preventing sleep onset; hypervigilance; the most complex sleep disruption pattern |
Good with professional involvement — CBD's fear extinction mechanism (FAAH/anandamide at amygdala CB1) is mechanistically aligned; physician/therapist involvement essential for PTSD |
FAAH inhibition supporting fear extinction; HPA hyperarousal reduction; Sleep Gummies for onset barriers; physician-directed PTSD care alongside CBD |
Positive but requiring patience and professional care; emerging RCT evidence is encouraging; 4–8 weeks for meaningful improvement with professional support |
Intellectual honesty about CBD and insomnia requires acknowledging what the evidence does not yet establish:
• No polysomnography (PSG) data in large human trials:PSG is the gold standard for objectively measuring sleep architecture — exactly how much time is spent in each sleep stage, how many awakenings occur, and what REM and deep sleep percentage looks like. Published CBD sleep studies have relied primarily on self-reported sleep quality measures and validated questionnaires (like the Pittsburgh Sleep Quality Index). Self-report is valuable but cannot confirm whether CBD changes sleep architecture in the ways the mechanism science predicts.
Many people approach CBD sleep supplements expecting the experience of a sleep medication:something that produces drowsiness within minutes and compels sleep regardless of the underlying cause. This expectation mismatch is responsible for many reports of CBD 'not working' for sleep.
Prescription hypnotics (zolpidem, eszopiclone) and benzodiazepine sleep aids work by potentiating GABA-A receptors — the same mechanism as alcohol — producing direct CNS sedation that forces sleep onset regardless of the underlying cause. This is effective in the short term but carries dependence risk, REM suppression, and next-morning cognitive impairment. More fundamentally, it does not address the reason sleep was disrupted — anxiety-driven cortisol, hyperarousal, racing mind — it simply overpowers it pharmacologically.
CBD does not force sleep. It addresses the neurobiological obstacles that are preventing sleep the body is otherwise ready for. Elevated cortisol blocking melatonin production → CBD modulates HPA. Racing anxious mind preventing neurological disengagement → CBD's 5-HT1A anxiolysis and amygdala calming. ECS-mediated sleep pressure insufficient → CBD's FAAH inhibition supports endocannabinoid tone in sleep regulatory centers. The sleep that follows CBD is not pharmacologically induced — it is the body's own natural sleep, unobstructed. This is both CBD's limitation (it requires the body to have the capacity for sleep) and its advantage (no REM suppression, no morning impairment, no dependence).
The consequence for expectations: CBD may not produce the dramatic sedation-within-30-minutes experience of a sleeping pill. The experience is typically subtler — the racing mind quiets, the body's tension releases, sleep onset occurs without the usually-unsuccessful effort that insomnia typically requires. For people expecting a pharmacological knockout, CBD will disappoint. For people whose sleep disruption is driven by anxiety-maintained hyperarousal, CBD's mechanism is precisely calibrated to what's happening.PureCraft's CBD+CBN Sleep Gummies add CBN's mild sedation and melatonin's circadian signal to produce a more perceptible effect than CBD alone — specifically designed to address the expectation gap while preserving the mechanism advantages.
CBT-I (Cognitive Behavioral Therapy for Insomnia) is the most rigorously evidence-supported treatment for chronic insomnia. Its components — sleep restriction, stimulus control, cognitive restructuring of beliefs about sleep, and relaxation techniques — address the behavioral and cognitive patterns that perpetuate insomnia once established.
CBD and CBT-I are not alternatives — they operate on different dimensions of the same problem. CBT-I addresses the behavioral and cognitive layer: the conditioned arousal that makes the bedroom a wakefulness cue, the meta-anxiety about not sleeping that guarantees continued sleeplessness, the sleep habits that are perpetuating the cycle. CBD addresses the neurobiological layer: the anxiety and HPA dysregulation that created the sleep problem and that CBT-I's cognitive restructuring must work against to produce change.
The mechanistic case for combining them: CBT-I's sleep restriction therapy and stimulus control work better when baseline anxiety is lower (because the behavioral exercises are harder to implement when anxiety is very high). CBD's anxiety reduction may create better neurological conditions for CBT-I's exercises to take effect — a complementary relationship analogous toCBD's complementary role with CBT for anxiety. If you have access to a CBT-I program (in-person therapy or validated digital programs), adding the CBD sleep protocol alongside CBT-I is an approach with strong mechanistic rationale even without a published head-to-head trial confirming it.
Based on the evidence reviewed above — particularly the Shannon case series, the de Aquino RCT, and the systematic reviews identifying anxiety-insomnia coupling as CBD's primary sleep mechanism — the protocol with the strongest evidence base is:
For the complete dosing protocol with body-weight adjustments, seeCBD Sleep Dosage: Finding the Right Dose and Timing. For the morning cortisol protocol that is the foundation of this approach, seeCBD Morning Routine for Anxiety: The Cortisol-First Approach.
For sleep onset improvement (falling asleep faster): typically 1–2 weeks of consistent nightlySleep Gummy use. For sleep quality improvement (more restorative, fewer awakenings, better deep sleep): 4–6 weeks of dailyNano CBD Oil plus nightly gummy. For early-morning waking reduction: 4–6 weeks of consistent AM oil specifically. The 3-month assessment in the Shannon case series is the appropriate evaluation window for full benefit — not 1–2 weeks.
At appropriate doses, CBD does not worsen insomnia. However, two specific scenarios can produce this appearance: (1) the inverted-U dose effect — very high doses of CBD can produce alerting effects in some people; if your CBD dose is causing difficulty sleeping, try reducing rather than increasing; (2) timing issues — CBD taken too late at night when it might produce mild alerting at high doses, or coffee and CBD used together in a way that amplifies rather than modulates cortisol. Start with the formulated Sleep Gummy at bedtime rather than high-dose oil, and maintain the morning oil protocol rather than a high-dose bedtime oil dose.
Partial evidence suggests yes — CBD's TRPV1 desensitization and CB2 anti-inflammatory mechanisms are relevant to pain-disrupted sleep, and CBD topicals for localized pain may address the pain dimension directly. The evidence is less robust than for anxiety-insomnia. For the specific pain-sleep application, seeCBD for Restless Legs and Night Waking: What Helps?. The general approach: daily AM oil for systemic anti-inflammatory and analgesic mechanisms, PM Sleep Gummies for immediate sleep barriers, CBD topicals for localized pain that disrupts sleep.
For anxiety-driven insomnia (most common):PureCraft's CBD+CBN Sleep Gummies at bedtime combined with daily morningNano CBD Oil. The three-mechanism Sleep Gummy (CBD + CBN + melatonin) addresses more insomnia barriers simultaneously than any single-compound product, and the Suraev systematic review specifically noted combination approaches as more effective. For non-anxiety insomnia with circadian component: the Sleep Gummy's melatonin is still useful; AM oil adds less without the anxiety dimension.
First confirm: was the use truly daily and consistent, including weekends? Was the product quality verified by COA? Was the dose in the 20–30mg therapeutic range for your weight? Was it combined with the AM oil protocol and the bedtime gummy? If yes to all: consider whether your insomnia has an anxiety component. If no anxiety is present, CBD's mechanism may be less relevant to your specific insomnia type — CBT-I from a sleep specialist may be more effective. If anxiety is present but CBD didn't help, dose titration (seeCBD Sleep Dosage) and physician consultation about concurrent anxiety treatment may be the next step.PureCraft's batch COA verification confirms product quality is not the issue.
CBD for insomnia is not proven in the way prescription sleep medications are proven — with large RCTs, FDA approval, and long-term outcome data. What it is: consistently associated with meaningful sleep improvement in the insomnia type that is most prevalent in people seeking CBD (anxiety and stress-driven secondary insomnia), with a safety profile dramatically better than pharmaceutical alternatives, through mechanisms that directly address the root cause of anxiety-driven sleep disruption rather than pharmacologically overriding it.
For the person whose insomnia is driven by an anxious mind that won't quiet at bedtime, a cortisol-elevated system that won't allow melatonin to rise, and a nervous system that never fully signals that it is safe to disengage — CBD's mechanism is among the most precisely calibrated interventions available without a prescription. Used correctly, consistently, at the right dose, with the morning-first protocol that the evidence supports, it addresses insomnia at its neurobiological root rather than suppressing its symptoms.
Start withPureCraft's CBD+CBN Sleep Gummies — 1 gummy 30–45 minutes before bed. AddNano CBD Oil 1000mg — 20–25mg each morning before coffee. Verify zero THC on your batch atpurecraftcbd.com/pages/faq. Nano-optimized for 90% bioavailability. USA-grown hemp. Consistent daily use for 6–8 weeks is the evidence-supported evaluation window.
Medical Disclaimer | This article is for informational purposes only. Chronic insomnia warrants professional evaluation. CBD is not a treatment for insomnia and should not replace physician-directed care or prescribed sleep medications. Individual results may vary.
Medical Disclaimer | Sauna use is contraindicated in certain cardiovascular conditions, pregnancy, and with medications that impair heat tolerance...
Read More
Medical Disclaimer | Cold water immersion is contraindicated in people with cardiovascular conditions, Raynaud's disease, hypertension, or cold ur...
Read More
Medical Disclaimer | This article is for informational and educational purposes only. Intermittent fasting and CBD supplementation should be appro...
Read More